Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Goserelin acetate |
Is a |
False |
Goserelin |
Inferred relationship |
Some |
|
Goserelin adverse reaction |
Causative agent (attribute) |
True |
Goserelin |
Inferred relationship |
Some |
1 |
Product containing goserelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Goserelin |
Inferred relationship |
Some |
1 |
Allergy to goserelin |
Causative agent (attribute) |
False |
Goserelin |
Inferred relationship |
Some |
|
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Goserelin |
Inferred relationship |
Some |
|
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Goserelin |
Inferred relationship |
Some |
|
Allergy to goserelin |
Causative agent (attribute) |
True |
Goserelin |
Inferred relationship |
Some |
1 |
Goserelin acetate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Goserelin |
Inferred relationship |
Some |
|
Goserelin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Goserelin |
Inferred relationship |
Some |
1 |
Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Goserelin |
Inferred relationship |
Some |
1 |
Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Goserelin |
Inferred relationship |
Some |
1 |
Product containing goserelin in subcutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Goserelin |
Inferred relationship |
Some |
1 |
Product containing only goserelin in subcutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Goserelin |
Inferred relationship |
Some |
1 |
Product containing only goserelin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Goserelin |
Inferred relationship |
Some |
1 |
Goserelin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Goserelin |
Inferred relationship |
Some |
1 |